SCHEMBL9214529

SCHEMBL9214529

O=C(CCl)N(Cc1ccccc1)CC(O)CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.51
▸ RAB9A P51151 4/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ ALDH1A1 P00352 6/20 0.50
▸ HTT P42858 3/20 0.50
▸ PAX8 Q06710 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ GLA P06280 1/20 0.50
▸ REN P00797 2/20 0.43
▸ ABCB1 P08183 2/20 0.42
▸ JAK2 O60674 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9209218 1.00 NPC1 (0.51) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL27847425 1.00 NPC1 (0.51) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL3468028 0.83 NPC1 (0.53) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL5451636 0.82 NPC1 (0.67) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL9220106 0.82 ABCB1 (0.46) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL9216460 0.82 ABCB1 (0.46) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL29254207 0.81 CRHBP (0.46) ALDH1A1SMN1; SMN2LMNACYP2C19TSHR
SCHEMBL29254204 0.81 CRHBP (0.46) ALDH1A1SMN1; SMN2LMNACYP2C19TSHR
SCHEMBL2902849 0.78 NPC1 (0.62) NPC1RAB9AKMT2AMEN1TDP1
SCHEMBL25181454 0.76 TDP1 (0.46) NPC1RAB9AKMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118324707-A Synthesis method of (S) -6-hydroxymethyl-morpholin-3-one 西安宇特邦医药科技有限公司 2024-07-12 — — CN claimed
CN-118324707-A Synthesis method of (S) -6-hydroxymethyl-morpholin-3-one 西安宇特邦医药科技有限公司 2024-07-12 — — CN disclosed
EP-0411912-B1 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders SANKYO CO (JP) 1995-04-19 — — EP disclosed
EP-0411912-A2 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders Sankyo Company Limited (JP) 1991-02-06 — — EP disclosed
Send feedback